Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015417
Filing Date
2021-11-10
Accepted
2021-11-10 10:35:29
Documents
54
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fencf-20210930x10q.htm   iXBRL 10-Q 1433429
2 EX-31.1 fencf-20210930xex31d1.htm EX-31.1 13963
3 EX-31.2 fencf-20210930xex31d2.htm EX-31.2 18491
4 EX-32.1 fencf-20210930xex32d1.htm EX-32.1 9311
5 EX-99.1 fencf-20210930xex99d1.htm EX-99.1 168923
6 GRAPHIC fencf-20210930xex99d1001.jpg GRAPHIC 2178
7 GRAPHIC fencf-20210930x10q002.jpg GRAPHIC 14330
  Complete submission text file 0001558370-21-015417.txt   5478687

Data Files

Seq Description Document Type Size
8 EX-101.SCH fencf-20210930.xsd EX-101.SCH 35034
9 EX-101.CAL fencf-20210930_cal.xml EX-101.CAL 31383
10 EX-101.DEF fencf-20210930_def.xml EX-101.DEF 146965
11 EX-101.LAB fencf-20210930_lab.xml EX-101.LAB 277320
12 EX-101.PRE fencf-20210930_pre.xml EX-101.PRE 255748
13 EXTRACTED XBRL INSTANCE DOCUMENT fencf-20210930x10q_htm.xml XML 914781
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 211395162
SIC: 2836 Biological Products, (No Diagnostic Substances)